BackGlobal Blood Therapeutics Overview

Global Blood Therapeutics Minority Interest

Global Blood Therapeutics's minority interest is $0.

Get informed when a big investor buys or sells

+ Follow
Minority Interest
$0.00

Peer trimmed avg / median

Loading

Global Blood Therapeutics Minority Interest History

Loading

Global Blood Therapeutics vs. peers: Minority Interest Comparison

Loading

Global Blood Therapeutics Minority Interest Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Global Blood Therapeutics (GBT) FAQ

The latest minority interest for GBT is $0 as of June 2022. In the prior-year period, the figure was $0. Investors often review this figure alongside Global Blood Therapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, GBT's minority interest moved from $0 to $0. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Global Blood Therapeutics's operating scale or balance-sheet position.

A minority interest figure of $0 for GBT is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting GBT's minority interest ($0), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Global Blood Therapeutics's minority interest against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.